N-Acetylcysteine and Atherosclerosis: Promises and Challenges
Antioxidants · 04.12.2023 · 12 (12) · 2073
DOI: 10.3390/antiox12122073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 04.12.2023. Verfasst von Yuqi Cui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 7220…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, US NIH.
Abstract (Originalsprache)
Atherosclerosis remains a leading cause of cardiovascular diseases. Although the mechanism for atherosclerosis is complex and has not been fully understood, inflammation and oxidative stress play a critical role in the development and progression of atherosclerosis. N-acetylcysteine (NAC) has been used as a mucolytic agent and an antidote for acetaminophen overdose with a well-established safety profile. NAC has antioxidant and anti-inflammatory effects through multiple mechanisms, including an increase in the intracellular glutathione level and an attenuation of the nuclear factor kappa-B mediated production of inflammatory cytokines like tumor necrosis factor-alpha and interleukins. Numerous animal studies have demonstrated that NAC significantly decreases the development and progression of atherosclerosis. However, the data on the outcomes of clinical studies in patients with atherosclerosis have been limited and inconsistent. The purpose of this review is to summarize the data on the effect of NAC on atherosclerosis from both pre-clinical and clinical studies and discuss the potential mechanisms of action of NAC on atherosclerosis, as well as challenges in the field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatrics, Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA.
- Center for Precision Medicine and Division of Cardiovascular Medicine, Department of Medicine, School of Medicine, University of Missouri, Columbia, MO 65212, USA.
ORCID-Profile: Yuqi Cui
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
- US NIH
Zitieren
APA
Cui, Y., Zhu, Q., Hao, H., Flaker, G. C., & Liu, Z. (2023). N-Acetylcysteine and Atherosclerosis: Promises and Challenges. Antioxidants, 12(12), 2073. https://doi.org/10.3390/antiox12122073
Vancouver
Cui Y, Zhu Q, Hao H, Flaker GC, Liu Z. N-Acetylcysteine and Atherosclerosis: Promises and Challenges. Antioxidants. 2023;12(12):2073. doi:10.3390/antiox12122073
BibTeX
@article{Cui2023,
author = {Cui, Yuqi and Zhu, Qiang and Hao, Hong and Flaker, Gregory C and Liu, Zhenguo},
title = {N-Acetylcysteine and Atherosclerosis: Promises and Challenges},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {12},
pages = {2073},
doi = {10.3390/antiox12122073}
}
EUVIMED